| HIV Infection |
1 |
1 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.99 |
| Health Care Reform |
0 |
0.73 |
| Outpatient Clinic |
0 |
0.98 |
| Canada |
0 |
0.46 |
| Fatigue |
0 |
0.37 |
| Viral Load |
0 |
0.28 |
| Revenue and Practice Management |
0 |
0.97 |
| Pain Management |
0 |
0.21 |
| Genomic Medicine |
0 |
0.19 |
| Health Insurance |
0 |
0.19 |
| Social Determinants of Health |
0 |
0.19 |
| AIDS |
0 |
0.18 |
| Dorsum |
0 |
0.18 |
| Insurance |
0 |
0.18 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.18 |
| Travel Medicine |
0 |
0.18 |
| Board Certification |
0 |
0.09 |
| CD4 |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Clinician Health and Well-Being |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Gluteal Region |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Health Care Quality, Access, and Evaluation |
0 |
0.09 |
| Medical Life |
0 |
0.09 |
| Microarray Technologies |
0 |
0.09 |
| Pain |
0 |
0.09 |
| Surgery |
0 |
0.09 |